July 6, 2007 (updated September 11, 2007) — The safety labeling for ceftriaxone sodium injection ( Rocephin; Roche Pharmaceuticals, Inc) has been updated to describe the potential risks associated ...
May 28, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to advise of potential decreases in bone mineral density in patients receiving long-term treatment with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback